Selvita S.A. (WSE:SLV)
30.00
-0.80 (-2.60%)
May 27, 2026, 12:50 PM CET
Selvita Revenue
Selvita had revenue of 79.99M PLN in the quarter ending March 31, 2026, a decrease of -12.28%. This brings the company's revenue in the last twelve months to 359.93M, up 0.04% year-over-year. In the year 2025, Selvita had annual revenue of 371.13M with 7.34% growth.
Revenue (ttm)
359.93M
Revenue Growth
+0.04%
P/S Ratio
1.57
Revenue / Employee
520.89K
Employees
691
Market Cap
565.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 371.13M | 25.37M | 7.34% |
| Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
| Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
| Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
| Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.42B |
| Centrum Medyczne ENEL-MED | 854.27M |
| Synektik Spólka Akcyjna | 706.45M |
| Mercator Medical | 585.57M |
| BIOTON | 282.52M |
| Celon Pharma | 226.35M |
| Ryvu Therapeutics | 88.38M |
Selvita News
- 6 days ago - Selvita Quarterly report: Q1 2026 - Filings
- 6 days ago - Selvita Slides: Q1 2026 - Filings
- 2 months ago - Selvita Annual report: Q4 2025 - Filings
- 2 months ago - Selvita Slides: Q4 2025 - Filings
- 6 months ago - Selvita Quarterly report: Q3 2025 - Filings
- 6 months ago - Selvita Slides: Q3 2025 - Filings
- 8 months ago - Selvita Quarterly report: Q2 2025 - Filings